Advertisements



Theravance Biopharma, Mylan report "positive" data from YUPELRI studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Theravance Biopharma, Mylan report data from Phase 3 studies of YUPELRI

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2018

Theravance, Mylan Report Positive Data on COPD Drug Yupelri

Theravance (TBPH) and partner Mylan post .....»»

Category: dealsSource: nytSep 18th, 2018

Theravance, Mylan Report Positive Data on COPD Drug Yupelri

Zacks.....»»

Category: topSource: redinewsSep 19th, 2018

Theravance Biopharma reports "positive" data from multiple studies of VIBATIV

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 8th, 2018

Theravance Biopharma, Mylan expand YUPELRI development agreement

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

Pluristem, Fukushima University report "positive" data from PLX-R18 studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 25th, 2018

Theravance Biopharma reports "positive" data from Phase 2 trial of TD-9855

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Bond Report: 10-, 30-year Treasury yields inch up Tuesday as U.S. stocks slide

Long-dated U.S. Treasury rates edge higher Tuesday, with appetite for bonds cooling even amid a round of weaker-than-expected housing data, which undercut the positive tone in equities......»»

Category: topSource: marketwatchMay 18th, 2021

Over 8 Million Jobs Below Pre-COVID Levels: ADP Employment Data Disappoints In April

Over 8 Million Jobs Below Pre-COVID Levels: ADP Employment Data Disappoints In April After a notable disappointment in the last two months, ADP's National Employment report was expected to print a very positive 850k ad.....»»

Category: smallbizSource: nytMay 5th, 2021

Nvidia Analyst Says New, Ampere-Based Data Center GPU Makes Chipmaker "Unassailable"

NVIDIA Corporation (NASDAQ: NVDA) shares, which have been bouncing along nicely for much of this week amid positive sell-side expectations for the chipmaker's earnings report next week, rose over 3.....»»

Category: blogSource: benzingaMay 15th, 2020

InDex Pharmaceuticals Holding AB (publ) Interim Report January - March 2020

STOCKHOLM, May 7, 2020 /PRNewswire/ -- FDA and EMA endorse the advancement of cobitolimod into phase III studies "The positive responses from the regulators is an important external validation of our study results and cobitolimod's po.....»»

Category: earningsSource: benzingaMay 7th, 2020

Gilead reports early positive data in remdesivir studies as COVID-19 drug, though Chinese trial sees no benefit

Gilead Sciences Inc.’s experimental dr.....»»

Category: topSource: marketwatchApr 29th, 2020

Theravance Biopharma announces publication of TD-1473 program data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 20th, 2020

NGM Biopharma Shares Spike Higher On Positive NASH Study Results

NGM Biopharmaceuticals Inc (NASDAQ: NGM) is advancing strongly on above-average volume Monday following a positive clinical data readout. read more.....»»

Category: blogSource: benzingaFeb 24th, 2020

How CTI BioPharma will use its $60M rights offering

The Seattle biotech, which was out of compliance with Nasdaq in December, has regained its standing due to positive data shared at a conference Dec. 9......»»

Category: topSource: bizjournalsFeb 21st, 2020

Acceleron Hits All-Time High On Positive Readout For Pulmonary Arterial Hypertension Drug

Shares of small-cap biopharma Acceleron Pharma Inc (NASDAQ: XLRN) are advancing to an all-time high Tuesday following a data readout. Latest Ratings for XL.....»»

Category: blogSource: benzingaJan 28th, 2020

TG Therapeutics shares rise on early-stage clinical data

Shares of TG Therapeutics Inc. gained 16% in premarket trading on positive data from small early-stage studies testing TG-1701 as .....»»

Category: topSource: marketwatchDec 9th, 2019

Principia Biopharma announces "consistent positive data" for PRN1008

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 7th, 2019

Accumulated Studies

FEEDI’ve received plenty of positive feedback from our introduction of the new “accumulation” data .....»»

Category: blogSource: slopeofhopeNov 27th, 2019

Akebia announces "positive" data from two Phase 3 vadadustat studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 10th, 2019